Showing results (31-40 of 331) with videos related to

Sort By:
Pageof 34
Scientific Reports|October 6, 2021
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatmentSo Yeon Oh, Soyeon Kim, Bhumsuk Keam, et al.
Cytotherapy|January 17, 2013
Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteersEun-Kyung Kim, Yong-Oon Ahn, Saerom Kim, et al.
Thoracic Cancer|April 24, 2018
Generalization and representativeness of phase III immune checkpoint blockade trials in non-small cell lung cancerShin Hye Yoo, Bhumsuk Keam, Miso Kim, et al.
Translational Oncology|July 29, 2026
In vitro evaluation of sacituzumab govitecan in non-small cell lung cancer with actionable genomic alterationsYerim Park, Soyeon Kim, Tae Min Kim, et al.
Cancer Research and Treatment|July 15, 2017
The Effect of Hospice Consultation on Aggressive Treatment of Lung CancerShin Hye Yoo, Bhumsuk Keam, Miso Kim, et al.
Cancer Treatment Reviews|April 19, 2025
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapyMakoto Tahara, Darren Wan-Teck Lim, Bhumsuk Keam, et al.
JAMA Network Open|September 9, 2025
Broad-Spectrum Antibiotic Use at the End of Life in Patients With Advanced CancerJeong-Han Kim, Jiwon Yu, Shin Hye Yoo, et al.
Cancer Research and Treatment|January 9, 2025
The Synergistic Effect of PARP Inhibitors and Irinotecan in Small Cell Lung Cancer CellsSongji Oh, Soyeon Kim, Bhumsuk Keam, et al.
Han'Guk Hosup'Isu Wanhwa Uiryo Hakhoe Chi = the Korean Journal of Hospice and Palliative Care|July 27, 2023
Barriers to Counseling on Advance Directives Based on Counselors' Experiences: Focus Group InterviewsYejin Kim, W, Shin Hye Yoo, et al.
Cancer Research and Treatment|February 18, 2015
Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single InstituteYounak Choi, Bhumsuk Keam, Tae Min Kim, et al.
Pageof 34